BP000253-CYT-473: Recombinant Human Transforming Growth Factor β-1 (TGFβ-1) Protein, GST Tag
Source: E. coli-derived.
Purity: > 80% by SDS-PAGE and RP-HPLC.BP000122-CYT-005: Recombinant Human Trefoil Factor-3
Source: E. coli-derived.
Determined by its ability to chemoattract human MCF-7 cells using a concentration 1.0-10.0 ug/ml
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000122-CYT-616: Recombinant Human Trefoil Factor-3, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000121-CYT-612: Recombinant Human Trefoil Factor 2 (TFF2) Protein
Source: E. coli-derived.
Determined by its ability to chemoattract human MCF-7 cells using a concentration 1.0-10.0 ug/ml.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000121-CYT-611: Recombinant Human Trefoil Factor 2 (TFF2) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP000120-CYT-586: Recombinant Human Trefoil Factor-1
Source: E. coli-derived.
Determined by its ability to activate ERK1/2 (a MAPkinase signaling molecule) using a concentration 1,000-2,000 ug/ml corresponding to a specific activity of 500-1,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000120-CYT-610: Recombinant Human Trefoil Factor-1, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000301-CHM-259: Recombinant Mouse Thymus Expressed Chemokine (CCL25)
Source: E. coli-derived.
Fully biologically active. Determined by its ability to chemoattract human CCR9 transfected BaF3 mouse pro-B cells using a concentration range of 0.1-0.5 ug/ml corresponding to a Specific Activity of 2-10 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000301-CHM-364: Recombinant Human Thymus Expressed Chemokine (CCL25)
Source: E. coli-derived.
Determined by its ability to chemoattract human monocytes using a concentration range of 1-10 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000403-TBE-284: Recombinant TBEV gE C-end
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WB, ELISA.